Anders Bruun Mathiasen
Anders Bruun Mathiasen
MD PhD, Rigshospitalet
Bekræftet mail på
Citeret af
Citeret af
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
J Lønborg, N Vejlstrup, H Kelbæk, HE Bøtker, WY Kim, AB Mathiasen, ...
European heart journal 33 (12), 1491-1499, 2012
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg, RS Oliveri, ...
The Lancet 382 (9898), 1113-1120, 2013
Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)
AB Mathiasen, AA Qayyum, E Jørgensen, S Helqvist, A Fischer-Nielsen, ...
European heart journal 36 (27), 1744-1753, 2015
Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design
AA Qayyum, M Haack-Sørensen, AB Mathiasen, E Jørgensen, A Ekblond, ...
Regenerative medicine 7 (3), 421-428, 2012
Pooled human platelet lysate versus fetal bovine serum—investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem …
SFT Kølle, RS Oliveri, PV Glovinski, M Kirchhoff, AB Mathiasen, JJ Elberg, ...
Cytotherapy 15 (9), 1086-1097, 2013
Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in …
AB Mathiasen, E Jørgensen, AA Qayyum, M Haack-Sørensen, A Ekblond, ...
American heart journal 164 (3), 285-291, 2012
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha
TS Larsen, KF Iversen, E Hansen, AB Mathiasen, C Marcher, ...
Leukemia research 37 (9), 1041-1045, 2013
Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina
T Friis, M Haack-Sørensen, AB Mathiasen, RS Ripa, US Kristoffersen, ...
Scandinavian Cardiovascular Journal 45 (3), 161-168, 2011
Mesenchymal stromal cells for cardiovascular repair: current status and future challenges
AB Mathiasen, M Haack-Sørensen, J Kastrup
Future Cardiology 5 (6), 605-617, 2009
Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina—final 3-year follow-up
AB Mathiasen, M Haack-Sørensen, E Jørgensen, J Kastrup
International journal of cardiology 170 (2), 246-251, 2013
Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study
JT Lønborg, T Engstrøm, JE Møller, KA Ahtarovski, H Kelbæk, ...
European Heart Journal–Cardiovascular Imaging 14 (2), 118-127, 2013
The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease
ND Mygind, MJ Harutyunyan, AB Mathiasen, RS Ripa, JJ Thune, ...
Inflammation research 60 (3), 281-287, 2011
Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up
M Haack-Sørensen, T Friis, AB Mathiasen, E Jørgensen, L Hansen, ...
Cell transplantation 22 (3), 521-528, 2013
Cryopreserved off‐the‐shelf allogeneic adipose‐derived stromal cells for therapy in patients with ischemic heart disease and heart failure—a safety study
J Kastrup, M Haack‐Sørensen, M Juhl, R Harary Søndergaard, B Follin, ...
Stem cells translational medicine 6 (11), 1963-1971, 2017
Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease
AB Mathiasen, MJ Harutyunyan, E Jørgensen, S Helqvist, R Ripa, ...
Scandinavian journal of clinical and laboratory investigation 71 (5), 439-447, 2011
Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols
J Lønborg, N Vejlstrup, AB Mathiasen, C Thomsen, JS Jensen, ...
Journal of Cardiovascular Magnetic Resonance 13 (1), 1-9, 2011
Bone marrow‐derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4‐year follow‐up of the MSC‐HF trial
AB Mathiasen, AA Qayyum, E Jørgensen, S Helqvist, KF Kofoed, ...
European journal of heart failure 22 (5), 884-892, 2020
High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial
MJ Harutyunyan, AB Mathiasen, P Winkel, JP Gøtze, JF Hansen, ...
Scandinavian journal of clinical and laboratory investigation 71 (1), 52-62, 2011
Adipose-derived stromal cells for treatment of patients with chronic ischemic heart disease (MyStromalCell trial): a randomized placebo-controlled study
AA Qayyum, AB Mathiasen, ND Mygind, JT Kühl, E Jørgensen, S Helqvist, ...
Stem cells international 2017, 2017
Optimal Labeling Dose, Labeling Time, and Magnetic Resonance Imaging Detection Limits of Ultrasmall Superparamagnetic Iron-Oxide Nanoparticle Labeled Mesenchymal Stromal Cells
AB Mathiasen, L Hansen, T Friis, C Thomsen, K Bhakoo, J Kastrup
Stem Cells International 2013, 2013
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20